Microbes, it seems, are not the only thing Japan is looking to develop in its medical lab.
J-Labs, the company behind the Japanese-language project, announced a new lab with the goal of using microorganisms to produce medicine and medical diagnostics.
The team has developed a method for the use of a synthetic microorganistic called Drosophila melanogaster as a source of microorganisms that are grown in a bioreactor.
The aim of the lab is to use this method to produce new medicines that could be tested in the laboratory and then in the field.
The Japanese government hopes to use the lab to produce medicines to treat conditions such as Crohn’s disease and inflammatory bowel disease.
The aim is to create medicines that are safe, effective and safe to consume.
The project is part of a broader initiative to produce synthetic microbes to help improve the world’s health, as well as create artificial life.
The government is also looking to use these new microorganisms as biocontrol agents.
The J-lab is located at the Shiga University of Science and Technology, and is the latest of several companies to open labs to study the possibilities of synthetic life.
Last year, a company called BioLab Japan opened a lab to study synthetic life in the United States.